Related references
Note: Only part of the references are listed.A Review of Computational Approaches Targeting SARS-CoV-2 Main Protease to the Discovery of New Potential Antiviral Compounds
Juan A. Castillo-Garit et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2023)
An in silico discovery of potential 3CL protease inhibitors of SARS-CoV-2 based upon inactivation of the cysteine 145-Histidine 41 catalytic dyad
Bibhudutta Mishra et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)
RNA-RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection
Song Zhang et al.
BRIEFINGS IN BIOINFORMATICS (2022)
Screening for Inhibitors of Main Protease in SARS-CoV-2: In Silico and In Vitro Approach Avoiding Peptidyl Secondary Amides
Kazuki Z. Yamamoto et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)
Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective
J. Carlos Menendez
MOLECULES (2022)
Design, synthesis and docking study of Vortioxetine derivatives as a SARS-CoV-2 main protease inhibitor
Hemant Suryavanshi et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compounds
Io Antonopoulou et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)
Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compounds
Io Antonopoulou et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)
Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2
Hadjer Khelfaoui et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
QSAR Modeling of SARS-CoV MproInhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and Other Drugs as Candidates for Repurposing against SARS-CoV-2
Vinicius M. Alves et al.
MOLECULAR INFORMATICS (2021)
The miRNA: a small but powerful RNA for COVID-19
Song Zhang et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
Hylemariam Mihiretie Mengist et al.
FRONTIERS IN CHEMISTRY (2021)
De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning
Marcos V. S. Santana et al.
BMC CHEMISTRY (2021)
SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
Andrea Citarella et al.
BIOMOLECULES (2021)
Docking-based virtual screening studies aiming at the covalent inhibition of SARS-CoV-2 MPro by targeting the cysteine 145
Laurent Soulere et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2021)
Emerging Building Blocks for Medicinal Chemistry: Recent Synthetic Advances
Oleksandr O. Grygorenko et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2021)
Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns
Hazem Mslati et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
Covalent Small Molecules as Enabling Platforms for Drug Discovery
Samuel E. Dalton et al.
CHEMBIOCHEM (2020)
Recent discovery and development of inhibitors targeting coronaviruses
Thanigaimalai Pillaiyar et al.
DRUG DISCOVERY TODAY (2020)
Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus
Sen Liu et al.
BIOINFORMATICS (2020)
Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition
Aleix Gimeno et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study
Junmei Wang
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds
Anh-Tien Ton et al.
MOLECULAR INFORMATICS (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates
Ryunosuke Yoshino et al.
SCIENTIFIC REPORTS (2020)
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
Alice Douangamath et al.
NATURE COMMUNICATIONS (2020)
Virtual screening of anti-HIV1 compounds against SARS-CoV-2: machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis
Mahesha Nand et al.
SCIENTIFIC REPORTS (2020)
Large-scale prediction of binding affinity in protein-small ligand complexes: the PRODIGY-LIG web server
Anna Vangone et al.
BIOINFORMATICS (2019)
Covalent Inhibition in Drug Discovery
Avick Kumar Ghosh et al.
CHEMMEDCHEM (2019)
Performance of HADDOCK and a simple contact-based protein-ligand binding affinity predictor in the D3R Grand Challenge 2
Zeynep Kurkcuoglu et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2018)
ProTox-II: a webserver for the prediction of toxicity of chemicals
Priyanka Banerjee et al.
NUCLEIC ACIDS RESEARCH (2018)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
Douglas E. V. Pires et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Deciphering key features in protein structures with the new ENDscript server
Xavier Robert et al.
NUCLEIC ACIDS RESEARCH (2014)
PubChem's BioAssay Database
Yanli Wang et al.
NUCLEIC ACIDS RESEARCH (2012)
LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery
Roman A. Laskowski et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
The resurgence of covalent drugs
Juswinder Singh et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Exploiting PubChem for virtual screening
Xiang-Qun Sean Xie
EXPERT OPINION ON DRUG DISCOVERY (2010)
Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design
Xiaoyu Xue et al.
JOURNAL OF VIROLOGY (2008)
Evaluation of docking accuracy and investigations of roles of parameters and each term in scoring functions for protein-ligand docking using ArgusLab software
Akifumi Oda et al.
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN (2007)
Docking and scoring in virtual screening for drug discovery: Methods and applications
DB Kitchen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
T-Coffee: A novel method for fast and accurate multiple sequence alignment
C Notredame et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Symplectic algorithm for constant-pressure molecular dynamics using a Nose-Poincare thermostat
JB Sturgeon et al.
JOURNAL OF CHEMICAL PHYSICS (2000)
Share Paper
